According to reporting by the Associated Press, the affected products were identified during routine quality testing, prompting immediate withdrawal from the market. Authorities have not reported any confirmed illnesses linked to the contaminated jars, but investigations are ongoing to determine the source and scope of the contamination.

Contamination Detected in Routine Testing

The contamination was discovered during internal checks conducted by the manufacturer, highlighting the role of quality assurance systems in food safety monitoring. Austrian food safety regulators confirmed the presence of a toxic compound typically used in rodenticides, though specific chemical details were not publicly disclosed.

Health officials stated that even trace exposure to such substances could pose risks, particularly for infants, whose developing systems are more vulnerable to toxins. As a precautionary measure, consumers have been advised to avoid using the recalled products and return them to retailers.

An initial risk assessment suggests limited distribution of the affected batches, but authorities emphasized that testing and traceability efforts are still underway.

Infant Food Safety Under Scrutiny

The recall has intensified attention on food safety protocols in the infant nutrition sector, where regulatory standards are among the strictest in the food industry. Experts note that contamination incidents, while rare, can undermine public confidence and highlight vulnerabilities in production or supply chains.

According to the World Health Organization, foodborne chemical exposure remains a global public health concern, particularly in products intended for infants and young children. The WHO emphasizes that even low-level contamination events require rapid response and transparent communication.

While no causal pathway has yet been confirmed, investigators are examining potential points of contamination, including raw material sourcing, processing environments, and packaging stages.

Regulatory Response and Product Recall

Austrian authorities have initiated a formal investigation and coordinated with European food safety bodies to assess whether the issue extends beyond national borders. The recall applies to specific batches distributed within Austria, with no immediate indication of wider international impact.

Regulators are also reviewing compliance with food safety standards and may consider additional inspections or enforcement measures depending on investigation findings. The European Union’s food safety framework requires rapid alert systems for such incidents, enabling cross-border information sharing.

HiPP said in a statement that it is cooperating fully with authorities and has implemented additional internal checks to prevent recurrence. The company emphasized that the recall was precautionary and part of its commitment to product safety.

Broader Implications for Public Health Monitoring

The incident underscores the importance of surveillance systems and routine testing in preventing potential health risks before products reach consumers. Public health experts highlight that early detection and swift recalls are critical in minimizing exposure, particularly among high-risk populations such as infants.

While no adverse health outcomes have been reported, authorities continue to monitor the situation and advise parents to follow official guidance. Further updates are expected as laboratory analyses and trace-back investigations progress.

The post HiPP Baby Food Recall Triggers Public Health Alert After Rat Poison Detection in Austria appeared first on Journos News - Breaking News, World News, Top Stories, Todays Headlines and Flash Reports.

Since mid-August, at least 13 infants aged 2 weeks to 5 months have been hospitalized after consuming ByHeart powdered formula, according to the U.S. Centers for Disease Control and Prevention (CDC). The affected states include Arizona, California, Illinois, Minnesota, New Jersey, Oregon, Pennsylvania, Rhode Island, Texas, and Washington. No deaths have been reported.

The California Department of Public Health warned consumers to stop using the product immediately. ByHeart, based in New York, has voluntarily recalled two lots of its Whole Nutrition Infant Formula, with a best-by date of December 2026, as additional testing continues.

Bold Italics: Bacteria Confirmed in Preliminary Tests

California health officials tested a can of powdered formula consumed by a sick infant. Preliminary results suggest the presence of the bacteria that produce botulism toxin, which has been confirmed in other cases. Further testing is required to validate these findings, as results can take several days.

ByHeart stated, “More testing is needed” to confirm whether the type of bacteria linked to botulism is present. The company emphasized that many bacteria in this family are naturally found in the environment and do not cause illness.

“We take this very seriously,” ByHeart said in a statement, adding that it is cooperating fully with federal authorities.

Bold Italics: Understanding Infant Botulism

Infant botulism is a rare condition that affects fewer than 200 babies in the U.S. each year. It occurs when bacteria produce toxins in the large intestine, leading to symptoms such as poor feeding, drooping eyelids, weak muscle tone, and difficulty breathing. Infants under one year are particularly vulnerable to the spores, which can be found in soil, dust, water, and certain foods like honey.

Dr. Steven Abrams, a nutrition expert at the University of Texas, noted that confirmed outbreaks linked to powdered infant formula are extremely rare. “This would be extremely rare,” he said, underscoring the unusual nature of the current cases.

Bold Italics: Treatment for Affected Infants

The only approved treatment for infant botulism is BabyBIG, an intravenous medication made from the pooled blood plasma of adults immunized against botulism. Developed by California’s Infant Botulism Treatment and Prevention Program, BabyBIG reduces the severity of illness and shortens hospital stays.

Because botulism can impair breathing, affected infants may require ventilators. The CDC reported that all infants in the ByHeart outbreak have received BabyBIG treatment.

Bold Italics: Impact on U.S. Formula Supply

Authorities do not anticipate any nationwide formula shortage resulting from this outbreak. ByHeart accounts for roughly 1% of U.S. formula sales, according to the CDC, and distributes products through its website and retail stores.

This situation contrasts with the 2021–2022 Abbott Nutrition crisis, when contamination issues forced nationwide recalls and triggered prolonged shortages. ByHeart previously recalled five batches in 2022 after a sample tested positive for a different germ, Cronobacter sakazakii, highlighting ongoing regulatory scrutiny.

Bold Italics: Federal Review of Infant Formula

The outbreak has renewed federal attention on infant nutrition safety. Health Secretary Robert F. Kennedy Jr. has directed the FDA to review the ingredients and nutrient content of infant formulas, marking the first major review since 1998. Dubbed “Operation Stork Speed,” the initiative will evaluate public, industry, and scientific input to determine potential improvements and next steps in infant formula regulation.

FDA officials are also investigating 83 cases of infant botulism reported since August, including the incidents linked to ByHeart formula.

Bold Italics: Safety Recommendations for Parents

Parents and caregivers are urged to check for any recalled ByHeart formula in their homes and discontinue use immediately. Healthcare providers recommend contacting a pediatrician if an infant shows signs of poor feeding, unusual weakness, drooping eyelids, or breathing difficulties.

Authorities stress that prompt treatment significantly improves outcomes for affected infants.

Source: AP News – Preliminary tests find germ that causes botulism in ByHeart baby formula

The post Tests Detect Botulism Bacteria in ByHeart Baby Formula appeared first on Journos News - Breaking News, World News, Top Stories, Todays Headlines and Flash Reports.

Formula Recall and Investigation

ByHeart Inc., a U.S.-based baby formula manufacturer, initiated a voluntary recall of two production lots—206VABP/251261P2 and 206VABP/251131P2—following reports of botulism infections. The FDA said Saturday that it is conducting a joint investigation with the Centers for Disease Control and Prevention (CDC) to determine the source and extent of the contamination.

No deaths have been reported. Officials emphasized that the recall is a precautionary measure as they assess whether any other batches were affected. The company’s products, available both online and through major retailers, represent roughly 1% of the national baby formula market, according to the CDC.

States Reporting Cases

The 13 confirmed cases have been identified in Arizona, California, Illinois, Minnesota, New Jersey, Oregon, Pennsylvania, Rhode Island, Texas, and Washington. All affected infants were hospitalized, but health officials have not disclosed further medical details.

Public Health Advisory

Authorities urged parents and caregivers who purchased ByHeart formula to immediately check the product lot numbers before discarding or returning any containers. The CDC advised consumers to record the lot number for reference and clean any bottles, utensils, or surfaces that came into contact with the recalled formula using a dishwasher or hot, soapy water.

The CDC also warned that symptoms of infant botulism can take several weeks to appear. Parents should seek medical attention immediately if their child shows signs such as poor feeding, weak crying, loss of head control, difficulty swallowing, or reduced facial expression.

Understanding Infant Botulism

Infant botulism is a rare but serious condition caused by Clostridium botulinum bacteria, which produce toxins in the intestines that can affect the nervous system. According to the CDC, it is most common in babies under one year old, particularly those between two and six months.

While most infants recover fully with prompt medical treatment, the illness can cause severe muscle weakness and breathing difficulties if untreated. The bacteria responsible for botulism are naturally found in soil and dust and can contaminate food or formula under certain conditions.

Ongoing Federal Oversight

The FDA said it is reviewing ByHeart’s manufacturing processes and supply chain records to determine how the contamination occurred. The agency’s investigation will also assess whether current food safety protocols for powdered infant formula were followed and if further actions are needed to prevent future incidents.

ByHeart, which markets its Whole Nutrition Infant Formula as made with organic ingredients and designed for sensitive digestion, has not yet issued a public statement beyond confirming cooperation with federal authorities.

Health experts note that the incident highlights ongoing safety concerns in the U.S. infant formula industry, which has faced heightened regulatory scrutiny since a major formula recall in 2022 led to nationwide shortages.

Consumer Safety Measures

The FDA and CDC reiterated that consumers should only use formula from verified safe batches and avoid feeding any recalled products to infants. Parents uncertain about formula safety can contact their pediatrician or report concerns directly to the FDA’s consumer complaint system.

The agencies are expected to release additional updates as testing and traceability efforts continue in the coming weeks.

Source: AP News – Infant botulism in 10 US states linked to formula being recalled

The post Infant Botulism Cases Linked to Recalled Baby Formula Under Federal Investigation appeared first on Journos News - Breaking News, World News, Top Stories, Todays Headlines and Flash Reports.

New research reveals that abortion bans in the United States are worsening existing health disparities, leading to increased births in high-risk populations and a significant rise in infant mortality.

Increased Births Following Abortion Bans

Since the Supreme Court’s Dobbs decision revoked the federal right to abortion, 14 states have implemented complete or six-week abortion bans. A study published in the medical journal JAMA found that in these states, the fertility rate increased by 1.7%, resulting in one additional birth per 1,000 women of reproductive age.

However, the consequences extend beyond an increase in births.

Infant Mortality Spikes in Banned States

A parallel study from the same research team uncovered an alarming rise in infant mortality in states with abortion bans. The infant death rate surged by nearly 6%, with about 500 more deaths than expected among the 22,000 additional births.

For births directly linked to abortion bans, the infant mortality rate stood at 24 deaths per 1,000 births—four times higher than expected. Researchers analyzed birth and death rates from 2012 to 2023, comparing trends before the bans with states that did not impose restrictions.

“These additional births are occurring disproportionately among populations at greater risk of infant mortality and other poor pregnancy outcomes,” said Dr. Suzanne Bell, assistant professor at the Johns Hopkins Bloomberg School of Public Health and co-author of the studies.

Disproportionate Impact on Vulnerable Populations

The research highlights how abortion bans disproportionately impact marginalized communities.

• Black women and other minorities experienced the largest increases in fertility rates.
• Lower-income groups, including Medicaid beneficiaries and those with lower education levels, also saw a sharp rise in births.
• Infant mortality surged nearly 11% among Black babies—almost double the average increase—making them the most affected racial or ethnic group.

“Abortion bans are associated with excess births that shift the composition of births toward those at higher risk of infant death,” the researchers wrote.

Experts have long warned about the dangers of abortion bans, emphasizing their impact on the health and well-being of families.

“The argument in the Dobbs case was that removing abortion rights wouldn’t affect measurable outcomes,” said Caitlin Myers, a professor of economics at Middlebury College who studies abortion trends. “Well, here’s one: increased infant mortality.”

Rise in Deaths Due to Congenital Anomalies

The studies also found a significant increase in infant deaths from congenital anomalies in states with abortion bans. These conditions, which can range from heart defects to severe spinal issues, often result in infants surviving only a few months.

• Infant deaths due to congenital anomalies rose by 11%, equating to one additional death per 10,000 births.
• Infant deaths from other causes also increased by 4% in states with abortion bans.

This suggests that even allowing abortion exceptions for fetal anomalies would not fully mitigate the negative effects of abortion bans on infant health.

“Many pregnant people were unable to overcome barriers to abortion access and were forced to carry unwanted or unsafe pregnancies to term,” said Bell. “The largest impacts are among populations already facing structural disadvantages and poor maternal and child health outcomes.”

Broader Maternal Health Impacts

The crisis extends beyond infant mortality. A CDC report found that Black women were the only group to experience an increase in maternal mortality from 2022 to 2023. The maternal death rate for Black women in 2023 was 50 deaths per 100,000 live births—nearly three times higher than other racial groups.

“[Abortion restrictions] are compounding existing health disparities by limiting reproductive autonomy,” Bell noted. “And the rise in infant deaths is likely just the tip of the iceberg.”

Texas: A Major Contributor to the Crisis

Texas played a significant role in the findings, accounting for:

• 75% of additional births
• 80% of additional infant deaths

Experts suggest several factors contributed to this outsized impact, including:

• The state’s early adoption of Senate Bill 8, which restricted abortion before the Dobbs decision.
• Long travel distances required for Texans seeking out-of-state abortion care.

Calls for Policy Change

In a commentary accompanying the research, Dr. Alyssa Bilinski, an assistant professor of health policy at Brown University, stressed the need for increased support for affected families.

“Abortion restrictions that force people to continue unexpected and high-risk pregnancies make it even more critical to ensure strong support systems for children and families,” she wrote in JAMA.

“There should be no partisan divide over the idea that all children and families deserve the opportunity to thrive.”

Conclusion

The studies provide clear evidence that abortion bans are not only increasing births but also worsening health outcomes for mothers and infants—especially among vulnerable populations. Experts warn that without policy changes and expanded healthcare support, the crisis is likely to deepen.

Source

The post Abortion Bans in the U.S. Linked to More Births and Higher Infant Deaths appeared first on Journos News - Breaking News, World News, Top Stories, Todays Headlines and Flash Reports.